Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating TRIV-509 in Atopic DermatitisCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorderActive, not recruitingPhase 22026-04-27NCT07167758

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Triveni Bio2

32 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Triveni Bio Site #1Camp HillUnited States1
Triveni Bio Site #10South BendUnited States1
Triveni Bio Site #11Fountain ValleyUnited States1
Triveni Bio Site #12Niagara FallsCanada1
Triveni Bio Site #13AjaxCanada1
Triveni Bio Site #15North YorkCanada1
Triveni Bio Site #16BellaireUnited States1
Triveni Bio Site #17NewmarketCanada1
Triveni Bio Site #18KyivUkraine1
Triveni Bio Site #21PragueCzechia1
Triveni Bio Site #22OstravaCzechia1
Triveni Bio Site #23PragueCzechia1
Triveni Bio Site #24ChorzówPoland1
Triveni Bio Site #25KatowicePoland1
Triveni Bio Site #26PoznanPoland1
Triveni Bio Site #27KatowicePoland1
Triveni Bio Site #28WarsawPoland1
Triveni Bio Site #29SosnowiecPoland1
Triveni Bio Site #3MiamiUnited States1
Triveni Bio Site #30PoznanPoland1
Triveni Bio Site #31PardubiceCzechia1
Triveni Bio Site #33WroclawPoland1
Triveni Bio Site #34BudapestHungary1
Triveni Bio Site #37PragueCzechia1
Triveni Bio Site #38PlevenBulgaria1